본문 바로가기
KERD
논문KCI 등재

젊은 성인여성에서 낮은 골밀도의 위험요인과 평가

Risk Factors and Assessment of Low Bone Mass in the Young Adult Female

2

조회

0

다운로드

11

인용

0

참고문헌

키워드

주제분류가정의학

초록

골다공증은 주로 폐경 후 여성에게 발생하지만 젊은 여성에 서도 골밀도가 낮거나 뼈 소실이 빠르게 일어나면 폐경 전이 라도 낮은 골밀도를 보일 수 있다. 실제 폐경 전 젊은 여성 중 일부는 골다공증의 위험이 있음에도 불구하고 젊은 여성에서 낮은 골밀도와 관련된 위험을 평가하고 관리하기 위한 지침 이 나와 있지 않기 때문에 임상에서 이를 다루기가 쉽지 않다. 젊은 여성에서 낮은 골밀도는 획득한 최대골밀도가 낮거나, 최대골밀도를 획득한 후 점진적으로 뼈 소실이 일어나 생긴 결과일 수 있다. 초기 뼈 건강은 향후 골다공증의 발생을 결정 짓는 중요한 요인이 되므로 젊은 성인기에 뼈 획득을 최적화 하고 폐경 전까지 뼈 소실을 최소화하는 것은 중요한 예방 전 략이 될 수 있다. 젊은 여성에서 낮은 골량은 지속적인 무월경, 신경성식욕부진, 장기간의 글루코코르티코이드치료, 칼슘과 비타민 D 대사에 영향을 주는 질환이나 약물치료와 관련이 있 으며, 흡연이나 체중감량, 칼슘섭취 부족, 운동 부족과 같은 환 경적 요인은 뼈 소실과 연관이 있다. 이 종설에서는 낮은 골량 과 관련된 위험인자를 리뷰하고, 골밀도가 낮은 젊은 성인여 성의 선별검사와 평가, 관리방법을 정리하였다.

Abstract

Although low bone mass and accelerated bone loss can occur early in life, osteoporosis is usually considered a disorder of postmenopausal women. However, some premenopausal women are also at risk for osteoporosis. Because of a lack of knowledge and few practice recommendations for premenopausal women, it can be more difficult to determine the potential risk and to manage the low bone mass in these women. Low bone density in the young adult female may refl ect attainment of a lower peak bone mass or be secondary to progressive bone loss following attainment of peak bone density. Early bone health is a key determinant of future osteoporosis, optimizing the bone gain by young adulthood and minimizing the bone loss by menopause is the important preventive strategies. Low bone mass in the young adult female may be associated with prolonged amenorrhea, anorexia nervosa, chronic glucocorticoid therapy and diseases that affect calcium and vitamin D metabolism. Also, bone loss may be associated with common conditions such as smoking, dieting, low calcium intake, and low physical activity. This review addresses peak bone mass accrual, risk factors, screening or evaluation and management of low bone mass in young adult female.

참고문헌 (60)

  1. Kanis JA, "Diagnosis of osteoporosis and assessment of fracture risk", Lancet, 359, pp.1929~1936 (2002)
  2. Kanis JA, "The diagnosis of osteoporosis", J Bone Miner Res, 9, pp.1137~1141 (1994)
  3. Lin YC, "Peak spine and femoral neck bone mass in young women", Bone, 32, pp.546~553 (2003)
  4. Seeman E, "Clinical review 137: sexual dimorphism in skeletal size, density, and strength", J Clin Endocrinol Metab, 86, pp.4576~4584 (2001)
  5. Seeman E, "Reduced bone mass in daughters of women with osteoporosis", N Engl J Med, 320, pp.554~558 (1989)
  6. Ferrari S, "Familial resemblance for bone mineral mass is expressed before puberty", J Clin Endocrinol Metab, 83, pp.358~361 (1998)
  7. Daniels ED, "Differences in mineral homeostasis, volumetric bone mass and femoral neck axis length in black and white South African women", Osteoporos Int, 7, pp.105~112 (1997)
  8. Lauderdale DS, "Hip fracture incidence among elderly Asian-American populations", Am J Epidemiol, 146, pp.502~509 (1997)
  9. Gourlay ML, "Clinical considerations in premenopausal osteoporosis", Arch Intern Med, 164, pp.603~614 (2004)
  10. Bonnick SL, "Dissimilar spine and femoral Z-scores in premenopausal women", Calcif Tissue Int, 61, pp.263~265 (1997)
  11. Chapurlat RD, "Longitudinal study of bone loss in pre- and perimenopausal women: evidence for bone loss in perimenopausal women", Osteoporos Int, 11, pp.493~498 (2000)
  12. Tudor-Locke C, "Factors related to variation in premenopausal bone mineral status: a health promotion approach", Osteoporos Int, 11, pp.1~24 (2000)
  13. Prior JC, "Spinal bone loss and ovulatory disturbances", N Engl J Med, 323, pp.1221~1227 (1990)
  14. Micklesfield LK, "Bone mineral density in mature, premenopausal ultramarathon runners", Med Sci Sports Exerc, 27, pp.688~696 (1995)
  15. Khan AA, "Bone densitometry in premenopausal women: synthesis and review", J Clin Densitom, 7, pp.85~92 (2004)
  16. Ramsdale SJ, "Dietary calcium intake relates to bone mineral density in premenopausal women", Br J Nutr, 71, pp.77~84 (1994)
  17. Recker RR, "Bone gain in young adult women", JAMA, 268, pp.2403~2408 (1992)
  18. Citron JT, "Spinal bone mineral loss in estrogen-replete, calcium replete premenopausal women", Osteoporos Int, 5, pp.228~233 (1995)
  19. Cooper C, "Dietary protein intake and bone mass in women", Calcif Tissue Int, 58, pp.320~325 (1996)
  20. Shapses SA, "Bone turnover and density in obese premenopausal women during moderate weight loss and calcium supplementation", J Bone Miner Res, 16, pp.1329~1336 (2001)
  21. Fogelholm GM, "Bone mineral density during reduction, maintenance and regain of body weight in premenopausal, obese women", Osteoporos Int, 12, pp.199~206 (2001)
  22. Salamone LM, "Effect of a lifestyle intervention on bone mineral density in premenopausal women: a randomized trial", Am J Clin Nutr, 70, pp.97~103 (1999)
  23. Fogelholm M, "Association between weight cycling history and bone mineral density in premenopausal women", Osteoporos Int, 7, pp.354~358 (1997)
  24. Wallace BA, "Systematic review of randomized trials of the effect of exercise on bone mass in pre-and postmenopausal women", Calcif Tissue Int, 67, pp.10~18 (2000)
  25. Goto S, "A longitudinal study for femoral neck bone mineral density increases in premenopausal caddies using dual-energy X-ray absorptiometry", J Bone Miner Metab, 19, pp.125~130 (2001)
  26. Winters KM, "Detraining reverses positive effects of exercise on the musculoskeletal system in premenopausal women", J Bone Miner Res, 15, pp.2495~2503 (2000)
  27. Myburgh KH, "Low bone mineral density at axial and appendicular sites in amenorrheic athletes", Med Sci Sports Exerc, 25, pp.1197~1202 (1993)
  28. Rencken ML, "Bone density at multiple skeletal sites in amenorrheic athletes", JAMA, 276, pp.238~240 (1996)
  29. Notelovitz M, "Estrogen therapy and variable resistance weight training increase bone mineral in surgically menopausal women", J Bone Miner Res, 6, pp.583~590 (1991)
  30. Anderson AE, "Bone mineral density of eating disorder subgroups", Int J Eat Disord, 18, pp.335~342 (1995)
  31. Davies KM, "Reduced bone mineral in patients with eating disorders", Bone, 11, pp.143~147 (1990)
  32. Ward A, "Persistent osteopenia after recovery from anorexia nervosa", Int J Eat Disord, 22, pp.71~75 (1997)
  33. Gourlay ML, "Clinical consideration in premenopausal osteoporosis", Arch Intern Med, 164, pp.603~614 (2004)
  34. Espallargues M, "Identifying bone mass–related risk factors for fracture to guide bone densitometry measurements: a systematic review of the literature", Osteoporos Int, 12, pp.811~822 (2001)
  35. Steinbuch M, "Oral glucocorticoid use is associated with an increased risk of fracture", Osteoporos Int, 15, pp.323~328 (2004)
  36. Gourlay ML, "Clinical consideration in premenopausal osteoporosis", Arch Intern Med, 164, pp.603~614 (2004)
  37. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-induced Osteoporosis, "Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update", Arthritis Rheum, 44, pp.1496~1503 (2001)
  38. Yood RA, "Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting", Arch Intern Med, 161, pp.1322~1327 (2001)
  39. Cummings SR, "Risk factors for hip fracture in white women: study of Osteoporotic Fractures Research Group", N Engl J Med, 332, pp.767~773 (1995)
  40. Caraballo RJ, "Changes in bone density after exposure to oral anticoagulants: a meta-analysis", Osteoporos Int, 9, pp.441~448 (1999)
  41. Pocock NA, "Effects of tobacco use on axial and appendicular bone mineral density", Bone, 10, pp.329~331 (1989)
  42. Hopper JL, "The bone density of female twins discordant for tobacco use", N Engl J Med, 330, pp.387~392 (1994)
  43. Krall EA, "Smoking and bone loss among postmenopausal women", J Bone Miner Res, 6, pp.331~338 (1991)
  44. MacMahon B, "Cigarette smoking and urinary estrogens", N Engl J Med, 307, pp.1062~1065 (1982)
  45. Lindsay R, "Bone mass and body composition in normal women", J Bone Miner Res, 7, pp.55~63 (1992)
  46. Prentice A, "Calcium requirements of lactating Gambian mothers: effects of a calcium supplement on breast-milk calcium concentration, maternal bone mineral content, and urinary calcium excretion", Am J Clin Nutr, 62, pp.58~67 (1995)
  47. Sowers MF, "Elevated parathyroid hormone-related peptide associated with lactation and bone density loss", JAMA, 276, pp.549~554 (1996)
  48. Alderman BW, "Reproductive history and postmenopausal risk of hip and forearm fracture", Am J Epidemiol, 124, pp.262~267 (1986)
  49. Dunne F, "Pregnancy associated osteoporosis", Clin Endocrinol (Oxf), 39, pp.487~490 (1993)
  50. Prior JC, "Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, populationbased data from the Canadian multicentre osteoporosis study", CMAJ, 165, pp.1023~1029 (2001)
  51. Polatti F, "Bone mass and long-term monophasic oral contraceptive treatment in young women", Contraception, 51, pp.221~224 (1995)
  52. Kroger H, "Prediction of fracture risk using axial bone mineral density in a perimenopausal population: a prospective study", J Bone Miner Res, 10, pp.302~306 (1995)
  53. Hosmer WD, "Fractures before menopause: a red flag for physicians", Osteoporos Int, 13, pp.337~341 (2002)
  54. Wu F, "Fractures between the ages of 20 and 50 years increase women's risk of subsequent fractures", Arch Intern Med, 162, pp.33~36 (2002)
  55. US Preventive Services Task Force, "Screening for osteoporosis in postmenopausal women: recommendations and rationale", Ann Intern Med, 137, pp.526~528 (2002)
  56. "Physician's guide to prevention and treatment of osteoporosis" (2008)[URL]
  57. Institute of Medicine Food and Nutrition Board's Standing Committee on the Scientific Evaluation of Dietary Intervals, "Dietary reference intakes for calcium, phosphorous, magnesium, vitamin D and fl uoride", pp.91~143 (1997), National Academy Press
  58. Pasco JA, "Oral contraceptives and bone mineral density: a population-based study", Am J Obstet Gynecol, 182, pp.265~269 (2000)
  59. Prior JC, "Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian multicentre osteoporosis study", CMAJ, 165, pp.1023~1029 (2001)
  60. Palomba S, "Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism", J Clin Endocrinol Metab, 87, pp.4476~4481 (2002)

관련 논문AI추천

이 간행물의 다른 논문 (6건)